IDENTIFYING NEW THERAPEUTIC TARGETS FOR HEPATOCELLULAR CARCINOMA (HCC) DISSECTING CATHEPSIN D ROLE IN THE INFLAMMATION-FIBROSIS-CANCER AXIS